Italia markets closed

ILMN Jun 2024 130.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
1,5900+0,0400 (+2,58%)
Alla chiusura: 03:58PM EDT
Schermo intero
Chiusura precedente1,5500
Aperto1,7000
Denaro1,4500
Lettera1,6000
Prezzo d'esercizio130,00
Scadenza2024-06-21
Min-Max giorno1,4500 - 1,7000
Contratto - Min-MaxN/D
Volume4
Open Interest409
  • GlobeNewswire

    Myriad Genetics and Illumina Achieve Milestones in Strategic Partnership to Support Biopharma Clinical Trials

    Myriad can conduct prospective clinical trials using Illumina’s TruSight Oncology Comprehensive Investigational Use Only testSALT LAKE CITY, Sept. 19, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced two key milestones in its strategic partnership with Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, to advance and support clinical research for gene-based, targeted thera